Edmonton, Canada

Robert M Ratcliffe

This inventor holds 4 USPTO granted patents. Top assignee: Chembiomed, Ltd.. Active years: 1988-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert M Ratcliffe. Retrieved from https://idiyas.com/inventor/robert-m-ratcliffe-iayxj5hq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1988-1989

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind: Robert M. Ratcliffe

Introduction: Robert M. Ratcliffe, an accomplished inventor based in Edmonton, Canada, has made significant contributions to the field of cancer diagnostics through his innovative patents. With a total of four patents to his name, Ratcliffe's work showcases the intersection of biomedical science and technological advancement.

Latest Patents: Among his notable inventions are two recent patents focused on tumor antigenic determinants. The first patent, titled "Synthesis of tumor antigenic determinant," outlines processes for synthesizing the human T-antigenic determinant 2-acetamido-2-deoxy-3-O-(β-D-galactopyranosyl)-α-D-galactopyranoside. This advancement involves coupling the determinant to carrier molecules to fabricate artificial T-antigens and insoluble supports to create T-immunoadsorbents. Importantly, the artificial T-antigen has been demonstrated to provoke a delayed type hypersensitivity reaction, serving as a diagnostic tool for identifying cancer in humans.

His second patent, "Method to detect T-antigen delayed hypersensitivity," elaborates on similar processes and emphasizes the utility of artificial T-antigens in cancer detection. These patents highlight Ratcliffe’s commitment to developing innovative solutions for critical healthcare challenges.

Career Highlights: Robert Ratcliffe's career is marked by his role at Chembiomed Ltd., where he has continued to advance the boundaries of biomedical research. His inventions not only illustrate his technical prowess but also his dedication to enhancing diagnostic capabilities in the fight against cancer.

Collaborations: Throughout his career, Ratcliffe has collaborated with esteemed colleagues, including Donald A. Baker and Raymond U. Lemieux. These partnerships have fostered a productive environment for innovation, allowing for the exchange of ideas and expertise in the field.

Conclusion: Robert M. Ratcliffe exemplifies the spirit of innovation in the realm of medical diagnostics. With his latest patents, he is paving the way for more effective cancer detection methods, demonstrating the vital role inventors play in advancing healthcare technology. His contributions not only reflect his genius but also represent a beacon of hope for early cancer diagnosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…